Prostate Cancer - Results from #22160

Prediction of prostate cancer to urethra distance by a pretreatment nomogram: Urethral thermoprotection implication in cryoablation - Abstract October 4, 2013

Role of endorectal prostate MRI in patients with initial suspicion of prostate cancer - Abstract October 4, 2013

Impact of statin use on biochemical recurrence in patients treated with radical prostatectomy- Abstract October 4, 2013

Abiraterone acetate: Targeting persistent androgen dependence in castration-resistant prostate cancer - Abstract October 3, 2013

Exercise preferences among men with prostate cancer receiving androgen-deprivation therapy - Abstract October 3, 2013

Nomograms to predict late urinary toxicity after prostate cancer radiotherapy - Abstract October 3, 2013

Challenging treatment decision-making in older urologic cancer patients - Abstract October 3, 2013

The influence of expertise of the surgical pathologist to undergrading, upgrading, and understaging of prostate cancer in patients undergoing subsequent radical prostatectomy - Abstract October 3, 2013

Update on positron emission tomography for imaging of prostate cancer - Abstract October 3, 2013

Detection and localization of carcinoma within the prostate using high resolution transrectal gamma imaging (TRGI) of monoclonal antibody directed at prostate specific membrane antigen (PSMA)-Proof of concept and initial imaging results - Abstract October 3, 2013

Preliminary experience with a novel method of three-dimensional co-registration of prostate cancer digital histology and in vivo multiparametric MRI - Abstract October 3, 2013

The role of elective pelvic radiotherapy in clinically node-negative prostate cancer: A systematic review - Abstract October 3, 2013

Pelvic irradiation in prostate cancer: What place for what volumes? - Abstract October 3, 2013

Five-year oncological outcomes of endoscopic extraperitoneal radical prostatectomy (EERPE) for prostate cancer: Results from a medium-volume UK centre - Abstract October 3, 2013

Targeted therapy in the treatment of castration-resistant prostate cancer - Abstract October 3, 2013

Bone marrow recovery and subsequent chemotherapy following radiolabeled anti-prostate-specific membrane antigen monoclonal antibody J591 in men with metastatic castration-resistant prostate cancer - Abstract October 3, 2013

Laparoscopic radical prostatectomy monotherapy, a more aggressive yet less invasive option, is oncologically effective in selected men with high-risk prostate cancer having only one D'Amico risk factor: Experience from an Asian tertiary referral center - October 3, 2013

Comprehensive analysis of sexual function outcome in prostate cancer patients after robot-assisted radical prostatectomy - Abstract October 3, 2013

Preoperative predictive model for biochemical recurrence in patients with localized prostate cancer treated with radical prostatectomy - Abstract October 3, 2013

Treatable and untreatable forms of recurrent prostate cancer - Abstract October 3, 2013

Page 1109 of 1437